Keyword search
Filter results by
Search HelpKeyword(s)
Year of publication
Survey or statistical program
Results
All (37)
All (37) (0 to 10 of 37 results)
- 1. The Canadian Bioproducts Industry, 2003 and 2006 ArchivedArticles and reports: 21-004-X200900110875Geography: CanadaDescription:
This study is a comparative analysis based on data from the Statistics Canada Bioproducts Development Survey (2003) and the Bioproducts Development and Production Survey 2006. This study examines the current state of the domestic industry, changes occurring over the period, and implications for agriculture.
Release date: 2009-06-11 - Articles and reports: 88-003-X200800110580Geography: CanadaDescription:
Data collected through Statistics Canada's life sciences statistics program indicate that Canada has a sizable biotechnology sector in comparison with larger countries in Europe. This program regularly provides assistance to other countries, which view Canada as a world leader in the development of biotechnology statistics. This article notes the future directions and challenges facing the program.
Release date: 2008-05-22 - 3. Biotechnology spinoffs: Transferring knowledge from universities and government labs to the marketplace ArchivedArticles and reports: 88-003-X200800110581Geography: CanadaDescription:
When an existing firm decides not to commercially develop a discovery, enterprising entrepreneurs may establish a spinoff organization to pursue the venture. Of the 532 biotechnology firms in Canada in 2005, 179 reported that they were spinoffs from another organization.
Release date: 2008-05-22 - 4. Results of the pilot survey on nanotechnologies ArchivedArticles and reports: 88-003-X200700210323Geography: CanadaDescription:
Although nanotechnology can be thought of as a sector of its own, it is clear that nanotechnology is a cross-sector phenomenon with potentially significant impacts. Nanotechnologies can be found in areas as diverse as biotechnology and health, agriculture, electronics and computer technology, environment and energy, optics, and in materials and manufacturing.
Release date: 2007-10-09 - Articles and reports: 88-003-X200700210324Geography: CanadaDescription:
Statistics Canada is actively involved with the international community in developing statistical information on nanotechnologies. This article summarizes the ongoing work of the OECD's newly-established Working Party on Nanotechnology, with particular emphasis on the role of Statistics Canada.
Release date: 2007-10-09 - Articles and reports: 88-003-X200700210325Geography: CanadaDescription:
Innovative biotechnology firms are science-based firms which attempt to bring an application of biotechnology to the market. However, it is clear that a significant proportion of these firms derive no revenue from product sales while their products proceed through the various phases of testing and regulatory approval. In order to support their operations they must look to other sources of funding.
Release date: 2007-10-09 - Articles and reports: 88-003-X200700210326Geography: CanadaDescription:
Although private investors and government funding agencies have learned that the biotechnology sector requires a funding model different from that of traditional manufacturing, there is a paucity of empirical research investigating the links between characteristics of the funding model and firm performance. The purpose of this article is to examine which funding sources have the greatest influence on firm growth.
Release date: 2007-10-09 - 8. Innovative biotech firms: Early results from the 2005 Biotechnology Use and Development Survey ArchivedArticles and reports: 88-003-X20070019620Geography: Canada, Province or territoryDescription:
Preliminary data from the Biotechnology Use and Development Survey (BUDS) 2005 indicate that growth continued in the sector, but at a slower pace than has been reported in earlier years. This article highlights some key biotechnology indicators for innovative biotech firms in Canada, by sector, size and province.
Release date: 2007-05-10 - 9. Defining bioproducts: a daunting challenge ArchivedArticles and reports: 88-003-X20060039534Geography: CanadaDescription:
Bioproducts play an important role in the search for solutions to declining reserves of oil, increasing costs of oil extraction, increasing oil prices and increasing greenhouse gas (GHG) concentration. They also offer opportunities for rural economic development and diversification for farmers. This article summarizes ongoing work towards improving our understanding of the bioproduct concepts and their definitions.
Release date: 2006-12-06 - Articles and reports: 88-003-X20060039538Geography: CanadaDescription:
Results from the Functional Foods and Nutraceuticals Survey 2005 indicate that there were 389 firms in Canada engaged in activities related to either functional foods, nutraceuticals or both during 2004/05. This article provides highlights of a group of firms which generates $29 billion in revenues and employs over 50,000 persons.
Release date: 2006-12-06
Data (0)
Data (0) (0 results)
No content available at this time.
Analysis (37)
Analysis (37) (0 to 10 of 37 results)
- 1. The Canadian Bioproducts Industry, 2003 and 2006 ArchivedArticles and reports: 21-004-X200900110875Geography: CanadaDescription:
This study is a comparative analysis based on data from the Statistics Canada Bioproducts Development Survey (2003) and the Bioproducts Development and Production Survey 2006. This study examines the current state of the domestic industry, changes occurring over the period, and implications for agriculture.
Release date: 2009-06-11 - Articles and reports: 88-003-X200800110580Geography: CanadaDescription:
Data collected through Statistics Canada's life sciences statistics program indicate that Canada has a sizable biotechnology sector in comparison with larger countries in Europe. This program regularly provides assistance to other countries, which view Canada as a world leader in the development of biotechnology statistics. This article notes the future directions and challenges facing the program.
Release date: 2008-05-22 - 3. Biotechnology spinoffs: Transferring knowledge from universities and government labs to the marketplace ArchivedArticles and reports: 88-003-X200800110581Geography: CanadaDescription:
When an existing firm decides not to commercially develop a discovery, enterprising entrepreneurs may establish a spinoff organization to pursue the venture. Of the 532 biotechnology firms in Canada in 2005, 179 reported that they were spinoffs from another organization.
Release date: 2008-05-22 - 4. Results of the pilot survey on nanotechnologies ArchivedArticles and reports: 88-003-X200700210323Geography: CanadaDescription:
Although nanotechnology can be thought of as a sector of its own, it is clear that nanotechnology is a cross-sector phenomenon with potentially significant impacts. Nanotechnologies can be found in areas as diverse as biotechnology and health, agriculture, electronics and computer technology, environment and energy, optics, and in materials and manufacturing.
Release date: 2007-10-09 - Articles and reports: 88-003-X200700210324Geography: CanadaDescription:
Statistics Canada is actively involved with the international community in developing statistical information on nanotechnologies. This article summarizes the ongoing work of the OECD's newly-established Working Party on Nanotechnology, with particular emphasis on the role of Statistics Canada.
Release date: 2007-10-09 - Articles and reports: 88-003-X200700210325Geography: CanadaDescription:
Innovative biotechnology firms are science-based firms which attempt to bring an application of biotechnology to the market. However, it is clear that a significant proportion of these firms derive no revenue from product sales while their products proceed through the various phases of testing and regulatory approval. In order to support their operations they must look to other sources of funding.
Release date: 2007-10-09 - Articles and reports: 88-003-X200700210326Geography: CanadaDescription:
Although private investors and government funding agencies have learned that the biotechnology sector requires a funding model different from that of traditional manufacturing, there is a paucity of empirical research investigating the links between characteristics of the funding model and firm performance. The purpose of this article is to examine which funding sources have the greatest influence on firm growth.
Release date: 2007-10-09 - 8. Innovative biotech firms: Early results from the 2005 Biotechnology Use and Development Survey ArchivedArticles and reports: 88-003-X20070019620Geography: Canada, Province or territoryDescription:
Preliminary data from the Biotechnology Use and Development Survey (BUDS) 2005 indicate that growth continued in the sector, but at a slower pace than has been reported in earlier years. This article highlights some key biotechnology indicators for innovative biotech firms in Canada, by sector, size and province.
Release date: 2007-05-10 - 9. Defining bioproducts: a daunting challenge ArchivedArticles and reports: 88-003-X20060039534Geography: CanadaDescription:
Bioproducts play an important role in the search for solutions to declining reserves of oil, increasing costs of oil extraction, increasing oil prices and increasing greenhouse gas (GHG) concentration. They also offer opportunities for rural economic development and diversification for farmers. This article summarizes ongoing work towards improving our understanding of the bioproduct concepts and their definitions.
Release date: 2006-12-06 - Articles and reports: 88-003-X20060039538Geography: CanadaDescription:
Results from the Functional Foods and Nutraceuticals Survey 2005 indicate that there were 389 firms in Canada engaged in activities related to either functional foods, nutraceuticals or both during 2004/05. This article provides highlights of a group of firms which generates $29 billion in revenues and employs over 50,000 persons.
Release date: 2006-12-06
Reference (0)
Reference (0) (0 results)
No content available at this time.
- Date modified: